Considerations for the management of urgency symptoms in patients with overactive bladder syndrome.
BACKGROUND
Traditionally, urinary frequency and/or urgency incontinence have been the primary outcome measurements for the symptom complex of overactive bladder (OAB). However, urgency, by definition, precedes urgency incontinence, and drives frequency and nocturia in OAB and should be considered in this pivotal role.


METHODS
Review of published literature on this topic.


RESULTS
The management of urgency is evolving as of major clinical importance to patients. Recent use of diary-based urgency metrics has advanced our knowledge of the presence and nature of urgency symptoms, the impact on QoL and the response to treatment options.


CONCLUSIONS
It is logical that the management of the number of urgency episodes and the degree of urgency, as well as the impact and bother associated with this core symptom are all taken into consideration along with patient interpretation to facilitate an effective outcome.
Cardozo
Linda D
LD
Department of Urogynaecology, King’s College Hospital, London SE5 9RS, UK. lcardozo@compuserve.com
Van Kerrebroeck
Philip E V A
PE
Staskin
David R
DR
D006801:Humans; D018727:Muscarinic Antagonists / Q000627:therapeutic use*; D053201:Urinary Bladder, Overactive / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D053202:Urinary Incontinence, Urge / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology
D018727:Muscarinic Antagonists
J Obstet Gynaecol. 2001 Jul;21(4):383-5
12521832
JAMA. 2002 Nov 13;288(18):2293-9
12425706
BMC Urol. 2007 Jun 11;7:9
17561998
BMJ. 2000 May 27;320(7247):1429-32
10827042
J Urol. 2006 Jul;176(1):177-85
16753396
J Urol. 2005 Jul;174(1):187-9
15947624
J Korean Med Sci. 2006 Dec;21(6):1060-3
17179687
BJU Int. 2004 Feb;93(3):303-10
14764127
J Urol. 2005 May;173(5):1639-43
15821526
J Urol. 2005 Aug;174(2):604-7
16006914
Eur Urol. 2008 Sep;54(3):543-62
18599186
Urology. 2008 Mar;71(3):449-54
18342185
Ann Intern Med. 2008 Aug 5;149(3):161-9
18678843
Urology. 2006 Nov;68(5):999-1004
17113893
BJU Int. 2008 Nov;102(9):1120-7
18990175
BJU Int. 2003 Jan;91(1):54-60
12614251
Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003193
17054163
BJU Int. 2005 Sep;96 Suppl 1:1-3
16086672
Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003781
17054185
J Urol. 2005 Jul;174(1):190-5
15947625
Urology. 2006 Aug;68(2 Suppl):38-48
16908339
Int J Clin Pract. 2008 Apr;62(4):606-13
18324952
Urology. 2008 May;71(5):839-43
18342923
Eur Urol. 2009 Apr;55(4):783-91
19157689
BJU Int. 2005 Sep;96 Suppl 1:37-42
16083453
J Adv Nurs. 2007 Jan;57(1):3-14
17184370
BMJ. 2003 Apr 19;326(7394):841-4
12702614
World J Urol. 2003 May;20(6):392-9
12811500
Obstet Gynecol. 2005 Nov;106(5 Pt 1):940-5
16260510
BJU Int. 1999 Oct;84(6):646-51
10510109
Eur Urol. 2004 Apr;45(4):420-9; discussion 429
15041104
J Am Geriatr Soc. 2002 May;50(5):799-807
12028164
JAMA. 2005 Feb 23;293(8):935-48
15728164
Int J Clin Pract. 2006 Jan;60(1):119-26
16409440
J Urol. 2004 Nov;172(5 Pt 1):1919-24
15540755
J Urol. 2006 Aug;176(2):636-40
16813910
BJU Int. 2007 Jan;99(1):101-6
17227496
Int J Urol. 2008 Jan;15(1):35-43
18184169
Eur J Obstet Gynecol Reprod Biol. 1992 Apr 21;44(2):137-44
1587379
BJOG. 2008 Jan;115(2):239-46
17970799
Neurourol Urodyn. 2002;21(2):167-78
11857671
J Urol. 2007 Sep;178(3 Pt 1):978-83; discussion 983-4
17632131
J Urol. 2005 Apr;173(4):1214-8
15758755
Br Med J. 1980 Nov 15;281(6251):1322-3
7002250
Urology. 2009 Jan;73(1):14-8
18995887
Drugs. 2006;66(10):1301-18
16903766
World J Urol. 2005 Sep;23(4):248-52
16096831
Curr Med Res Opin. 2008 Jun;24(6):1583-91
18423103
Neurourol Urodyn. 2006;25(7):709-16
16998862
Eur Urol. 2005 Jul;48(1):5-26
15885877
Eur Urol. 2007 Dec;52(6):1744-50
17822835
J Urol. 2004 Jun;171(6 Pt 1):2311-5, quiz 2435
15126811
Eur Urol. 2005 Sep;48(3):464-70
15990220